RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q2 2024 · 256 positions · Total reported value $1.67B · Top-10 concentration 27.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 256 equity positions with a combined reported value of $1.67B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 27.6% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q2 2024 were LRN ($60.91M), DFIN ($52.15M), ACIW ($51.00M). By sector, the heaviest allocations are Health Care 26.8%, Consumer Discretionary 26.6%. Versus the prior quarter, allocation shifted toward Technology (+1.5pp), Consumer Discretionary (+0.9pp) and away from Industrials (-0.6pp), Other (-1.7pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 93% of names.

The largest new positions opened in Q2 2024 were GENI ($5.52M), FIGS ($3.86M), WEX ($3.53M).

Of the 12 positions fully exited versus the prior quarter, the largest were DOOR ($51.86M), MODN ($4.93M), MYRG ($3.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • GENI GENIUS SPORTS LIMITED · $5.52M
  • FIGS FIGS INC · $3.86M
  • WEX WEX INC · $3.53M
  • AMSC AMERICAN SUPERCONDUCTOR CORP · $3.47M
  • MIR MIRION TECHNOLOGIES INC · $2.38M
  • NVTS NAVITAS SEMICONDUCTOR CORP · $2.15M
  • PLRX PLIANT THERAPEUTICS INC · $1.37M
  • ASUR ASURE SOFTWARE INC · $782.44K

Fully Exited (vs previous quarter)

  • DOOR MASONITE INTERNATIONAL CORP · prev qtr: $51.86M
  • MODN MODEL N INC · prev qtr: $4.93M
  • MYRG MYR GROUP INC · prev qtr: $3.40M
  • ALNT ALLIENT INC · prev qtr: $2.56M
  • VIAV VIAVI SOLUTIONS INC · prev qtr: $1.77M
  • ZUMZ ZUMIEZ INC · prev qtr: $1.66M
  • NOTVQ INOTIV INC · prev qtr: $1.56M
  • INTC INTEL CORP · prev qtr: $247.35K

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 26.8%
Technology 14.1%
Financials 6.3%
Other 13.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 863.92K $60.91M 3.65%
3.65%
Reduce
2 874.70K $52.15M 3.13%
3.13%
Reduce
3 1.29M $51.00M 3.06%
3.06%
Reduce
4 3.88M $50.57M 3.03%
3.03%
Reduce
5 113.49K $46.74M 2.80%
2.80%
Reduce
6 847.33K $44.49M 2.67%
2.67%
Reduce
7 406.05K $43.85M 2.63%
2.63%
Reduce
8 592.26K $40.78M 2.45%
2.45%
Reduce
9 354.87K $36.73M 2.20%
2.20%
Reduce
10 134.52K $32.93M 1.98%
1.98%
Add
11 716.34K $32.55M 1.95%
1.95%
Reduce
12 271.16K $28.78M 1.73%
1.73%
Reduce
13 998.62K $28.57M 1.71%
1.71%
Reduce
14 155.64K $28.14M 1.69%
1.69%
Reduce
15 451.80K $24.87M 1.49%
1.49%
Add
16 292.48K $24.64M 1.48%
1.48%
Add
17 214.56K $24.30M 1.46%
1.46%
Reduce
18 1.20M $22.45M 1.35%
1.35%
Add
19 151.66K $20.68M 1.24%
1.24%
Reduce
20 723.37K $20.23M 1.21%
1.21%
Reduce
21 503.83K $19.15M 1.15%
1.15%
Reduce
22 333.89K $19.08M 1.15%
1.15%
Reduce
23 225.92K $18.59M 1.11%
1.11%
Reduce
24 372.19K $16.27M 0.98%
0.98%
Reduce
25 118.11K $16.26M 0.97%
0.97%
Reduce
26 875.53K $15.97M 0.96%
0.96%
Reduce
27 97.72K $15.55M 0.93%
0.93%
Reduce
28 176.62K $15.14M 0.91%
0.91%
Reduce
29 376.23K $14.56M 0.87%
0.87%
Add
30 180.38K $13.77M 0.83%
0.83%
Reduce
31 939.58K $13.59M 0.81%
0.81%
Add
32 880.97K $13.47M 0.81%
0.81%
Add
33 502.59K $13.44M 0.81%
0.81%
Reduce
34 283.86K $13.28M 0.80%
0.80%
Reduce
35 322.89K $13.24M 0.79%
0.79%
Reduce
36 1.64M $13.12M 0.79%
0.79%
Reduce
37 1.16M $12.94M 0.78%
0.78%
Reduce
38 2.08M $12.85M 0.77%
0.77%
Reduce
39 73.35K $12.63M 0.76%
0.76%
Add
40 742.93K $12.07M 0.72%
0.72%
Add
41 38.61K $11.87M 0.71%
0.71%
Reduce
42 64.66K $11.65M 0.70%
0.70%
Reduce
43 467.76K $11.27M 0.68%
0.68%
Add
44 600.63K $11.21M 0.67%
0.67%
Reduce
45 444.04K $10.94M 0.66%
0.66%
Add
46 446.40K $10.65M 0.64%
0.64%
Reduce
47 102.22K $10.57M 0.63%
0.63%
Reduce
48 355.55K $10.26M 0.61%
0.61%
Reduce
49 196.43K $10.20M 0.61%
0.61%
Reduce
50 2.07M $10.00M 0.60%
0.60%
Reduce

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 256 equity positions worth $1.67B in aggregate; its largest disclosed positions were LRN ($60.91M), DFIN ($52.15M), ACIW ($51.00M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.67B of long equity holdings across 256 positions as of 2024-Q2. Top-10 holdings account for 27.6% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →